IPP Bureau
GPCB issues directive for closure of Tatva Chintan Pharma Chem Ankleshwar plant
By IPP Bureau - September 14, 2024
GPCB has also asked to submit a bank guarantee of Rs. 2, 00,000 for compliance assurance at the time of revocation and has also ordered to deposit interim environment damage compensation amount
Zydus announces licensing and supply agreement for two Gadolinium based MRI injectable
By IPP Bureau - September 14, 2024
Both the products are Gadolinium based Magnetic Resonance Imaging (MRI) contrast agents and will be the first set of contrast agent products in Zydus’ injectable portfolio for the US market
Briefs: RPG Life Sciences and Lasa Supergenerics
By IPP Bureau - September 14, 2024
Lasa Supergenerics Limited has been granted patent for an invention “Processes for Preparation and Purification of 5-Chloro-2-Nitroaniline
USFDA concludes audit for Laurus Labs’ API manufacturing facility at Hyderabad with zero Form 483 observations
By IPP Bureau - September 14, 2024
The USFDA inspection focused on evaluating the facility's adherence to global regulatory requirements and best practices
Max Healthcare collaborates with Lakshdeep Group for revival and turnaround of Jaypee Healthcare
By IPP Bureau - September 14, 2024
The acquisition is based on an enterprise value of Rs. 1,660 crore
DFC commits US $20 mn loan to Panacea Biotec towards capacity expansion for hexavalent vaccine
By IPP Bureau - September 13, 2024
The wP-IPV-based hexavalent vaccination is an innovative immunization alternative to the current pentavalent and standalone IPV vaccines
Strides secures shareholders approval for OneSource CDMO
By IPP Bureau - September 12, 2024
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
Briefs: Medicamen Biotech, Aurobindo Pharma and Ajooni Biotech
By IPP Bureau - September 12, 2024
The sANDA was submitted as “Prior Approval Supplement” for addition of an alternate drug product manufacturing, labeling, packaging, and testing facility
India approves health insurance cover of Rs 5 lakh for all aged 70 years and above
By IPP Bureau - September 12, 2024
This aims to benefit approximately 4.5 crore families with six crore senior citizens with Rs. 5 lakh free health insurance cover on a family basis
Ayush Ministry resolves 1346 Public Grievances under the Special Campaign 3.0
By IPP Bureau - September 12, 2024
Secretary Vaidya Rajesh Kotecha has urged senior officials to strive for the successful attainment of targets during the campaign
Merck launches single-use reactor to accelerate ADC manufacturing
By IPP Bureau - September 12, 2024
Increases efficiency by 70% compared to stainless steel or glass manufacturing methods
AGC and Medinet sign agreement for cell therapy CDMO business
By IPP Bureau - September 12, 2024
A new initiative to contribute to enhancing drug discovery capabilities in the field of gene and cell therapy in Japan
USFDA determines inspection classification of VAI for the contract manufacturing facility at Spokane, Washington
By IPP Bureau - September 11, 2024
Jubilant HollisterStier is a subsidiary of Jubilant Pharma Holding
Zydus Lifesciences announces completion of Phase II(a) clinical trial of Usnoflast
By IPP Bureau - September 11, 2024
ALS patients experience neuroinflammation and rapid neurodegeneration
Evonik starts operation of new spray drying facility for pharmaceutical oral excipients
By IPP Bureau - September 11, 2024
Investment in new plant meets increasing demand for functional excipients for oral drug delivery
